The global epigenetics market size was USD 9,143.1 Million in 2020 and is expected to reach a value of USD 36.52 Billion by 2028, and register a CAGR of 18.8% during the forecast period. Rising prevalence of various types of cancer and other chronic diseases, growing global geriatric population, and need for advanced treatment and pharmaceuticals are major factors expected to drive market growth. There has been a significant increase in the number of people suffering from cancer across the globe. According to WHO, the number of people suffering from cancer is expected to increase from 14.1 Million in 2012 to 19.3 Million by 2025.

Epigenetic changes such as dysregulation of DNA methylation are associated with cancer development and progression. Epigenetics provides new opportunities for deriving therapeutic strategies designed to reverse dysregulation in cancer. Various cancer research studies that utilize epigenetics technique are currently underway; significant investments are being made to support these studies. For instance, in February 2016, the University of Southampton and University Hospitals Southampton NHS Foundation Trust (UK) received USD 1.57 Million for genetics and Genomics research related to cancer and infectious diseases.

An analysis of Epigenetics’s growth rate, market share, market size, current and emerging trends, production and consumption ratios, industrial chain analysis, demand and supply, import and export, revenue contribution, and presence of key players is provided in the report, which has been segmented into key regions globally. This report provides a country-by-country analysis of the Epigenetics market to give a clearer picture of its regional distribution and growth.

Request a sample report of Epigenetics Market @ https://www.reportsanddata.com/download-free-sample/2079

In the pharmaceutical and healthcare sectors, there is rapid change. As cell and gene therapies become increasingly available, patients are finding appropriate treatments for previously incurable diseases. Machine learning and artificial intelligence (AI) technologies are making it possible for more inventive, faster, and cheaper therapy development to take place. By utilizing data-driven projects, manufacturing, the supply chain, and the entire healthcare ecosystem can benefit. It is clear that consumer attitudes and behaviors are shifting, ranging from a greater use of technology and data sharing to a willingness to use tools to make prescriptions and treatment decisions. Pharma and healthcare markets are expected to grow in the next few years as a result of such factors.

Key Players covered in this report are

Illumina (U.S.), Thermo Fisher Scientific (U.S.), Merck Millipore (U.S.), Abcam (U.K.), Active Motif (U.S.), Bio-Rad Laboratories (U.S.), New England Biolabs (U.S.), Agilent (U.S.), QIAGEN (Netherlands), Zymo Research (U.S.), PerkinElmer (U.S.), and Diagenode (Belgium).

Segments covered in the report:

By Product Outlook

• Reagents
• Kits
• Chip sequencing kit
• Whole Genomic Amplification kit
• Bisulfite Conversion kit
• RNA sequencing kit
• Others
• Instruments
• Enzymes
• Services

By Technology Outlook

• DNA Methylation
• Histone Methylation
• Histone Acetylation
• Large non — coding RNA
• MicroRNA modification
• Chromatin structures

By Application Outlook

• Oncology
• Solid tumors
• Liquid tumors
• Non — oncology
• Inflammatory diseases
• Metabolic diseases
• Infectious diseases
• Cardiovascular diseases
• Others

Read the full report @ https://www.reportsanddata.com/report-detail/epigenetics-market

Based on Region market is segmented into:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Major Points covered in this report are as below:

• An analysis of Epigenetics industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.
• In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.
• In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.
• This report provides information on the market status of Epigenetics manufacturers and provides valuable insight into the market for companies and individuals.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2079

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Browse More Reports:

Acrylamide Market @ https://www.reportsanddata.com/report-detail/acrylamide-market

Propylene Market @ https://www.reportsanddata.com/report-detail/propylene-market

Intensive Care Unit (ICU) Beds Market @ https://www.reportsanddata.com/report-detail/icu-beds-market

Betaine Market @ https://www.reportsanddata.com/report-detail/betaine-market

Plastics Injection Molding Machine Market @ https://www.reportsanddata.com/report-detail/plastic-injection-molding-machine-market

Pharmaceutical Grade Sodium Chloride Market @ https://www.reportsanddata.com/report-detail/pharmaceutical-grade-sodium-chloride-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1–212–710–1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report